SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLASs guidance that topline results from its Phase 3 REGAL trial of GPS in AML are expected in November has put the pending readout at the center of attention. Traders reacted to the narrowed timeline with excitement and short-squeeze speculation, while others caution that the results are still pending and the trials outcome is uncertain.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

A widespread Microsoft 365 outage disrupting Outlook, Teams and other services sparked complaints and concern about business impact; traders debated whether the disruption should weigh more heavily on the stock, while cyberattack claims remained speculation. Later discussion also focused on whether Anthropics Claude workplace tools could challenge Office, with some seeing competitive risk and others arguing Microsofts enterprise integration is difficult to displace.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candels prostate-cancer BLA filing has been pushed to mid-2027 amid FDA discussions and assay refinement, prompting a sharp selloff. Traders are divided over whether this is a manageable manufacturing and CMC delay that leaves the clinical data intact or a sign of execution problems; many also criticize management and worry about dilution.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

Hot inflation data and expectations of Fed rate hikes have lifted Treasury yields and the dollar, pressuring gold and driving a sharp GLD selloff. Traders are split between anticipating more downside and treating the decline as a buying opportunity or setup for a rebound.

Cisco Systems, Inc. engages in the design, manufacture, and sale of Internet Protocol-based networking products and services related to the communications and information technology industry. The firm operates through the following geographical segments: the Americas, EMEA, and APJC. Its products include the following categories: Secure, Agile Networks, Internet for the Future, Collaboration, End-to-End Security, Optimized Application Experiences, and Other Products. The company was founded by Sandra Lerner and Leonard Bosack in 1984 and is headquartered in San Jose, CA.

Cisco Systems, Inc.

Ciscos quarterly results beat expectations and came with raised full-year guidance and a higher AI-infrastructure outlook. Traders are split over the muted, volatile share reaction: some see strong growth and networking demand, while others cite profit-taking and concerns about margins, inventory, and whether AI orders will translate into sustained revenue.

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,111,281. The last known price of Bitcoin is 71,086.72423286 USD and is down -3.89 over the last 24 hours. It is currently trading on 12779 active market(s) with $28,515,435,687.36 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

Bitcoins prolonged selloff and break of key support dominate the discussion, with traders citing risk-off conditions, a stronger dollar and rising yields, ETF outflows, and leveraged long liquidations as pressures. Bearish calls for more downside outweigh bullish views, though some traders see oversold conditions and lower levels as opportunities to accumulate.

Modine Manufacturing Co. engages in the provision of thermal management products and solutions. It operates through the Climate Solutions and Performance Technologies business segments. The Climate Solutions segment provides climate-controlled solutions and components, heat transfer products, heating, ventilating, air conditioning and refrigeration products, and data center cooling solutions. The Performance Technologies segment designs and manufactures air- and liquid-cooled technology for vehicular, stationary power, and industrial applications. In addition, the Performance Technologies segment provides thermal solutions to zero-emission and hybrid commercial vehicle and automotive customers, and coating products and application services. The company was founded by Arthur B. Modine on June 23, 1916 and is headquartered in Racine, WI.

Modine Manufacturing Co.

Reported Samsung discussions to acquire Modine are driving attention, with traders weighing the possibility of a buyout premium against skepticism that talks will produce a deal and concern that the surge could fade. No agreement has been announced.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras quarterly results and stronger forward revenue guidance, alongside discussion of a Microsoft deal, are driving attention. Bulls see the outlook and customer expansion as signs of growing AI-inference demand, while skeptics focus on losses, heavy spending and execution risks; short-squeeze talk remains speculative.

Applied Materials, Inc. engages in provision of materials engineering solutions used to produce semiconductors. The firm also focuses on design, development, production, and servicing of the critical wafer fabrication tools used for customers to manufacture semiconductors. It operates through the following segments: Semiconductor Systems and Applied Global Services (AGS). The Semiconductor Systems segment includes designing, development, manufacturing and sale of equipment used to fabricate semiconductor chips referred to as integrated circuits. The AGS segment engages in provision of services, spares, and factory automation software to customer fabrication plants globally. The company was founded on November 10, 1967 and is headquartered in Santa Clara, CA.

Applied Materials Inc.

Applied Materials quarterly results and next-quarter outlook beat expectations, but the shares fell despite the strong report. Traders are split between viewing the results and guidance as evidence of robust chip-equipment demand and arguing the good news was already priced in, with the muted reaction amplified by broader tech weakness.

Flowers Foods, Inc. engages in the production and marketing of packaged bakery foods. It offers breads, buns, rolls, snack items, bagels, English muffins, and tortillas and are sold under a variety of brand names, including Nature’s Own, Dave’s Killer Bread, Wonder, Canyon Bakehouse, Tastykake, and Mrs. Freshley’s. The company was founded by William Howard Flowers, Sr. and Joseph Hampton Flowers, Jr. in 1919 and is headquartered in Thomasville, GA.

Flowers Foods, Inc.

Weak quarterly results and a reduced outlook, alongside falling bread volumes, margin pressure and heavy debt, are driving concern about Flowers Foods ability to stabilize and maintain its dividend. Some traders view the selloff and high short interest as a potential rebound or squeeze setup, while others focus on worsening fundamentals; speculation about a Tastykake sale also appears in the discussion.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

then the back half of the month
Nov 25 $SNY venglustat in type 3 Gaucher, first US shot at the brain side of the disease. Nov 27 BBIO BBP 418 in LGMD, first therapy for that form if it lands. Nov 28 $PYPD DPLEX100 for surgical infections, Saturday date so Friday is the window
Nov 30 $VRTX povetacicept in IgAN and Cogent bezuclastinib in GIST, plus $GSK neladalkib still expected in November with no day given

TheSuper

StockTwits Web

Sanofi-Aventis

Polypid Ltd

Vertex Pharmaceuticals, Inc.

Glaxosmithkline plc - ADR

 venglustat in type 3 Gaucher, first US shot at the brain side of the disease. Nov 27 BBIO BBP 418 in LGMD, first therapy for that form if it lands. Nov 28 

 DPLEX100 for surgical infections, Saturday date so Friday is the window
Nov 30 

 povetacicept in IgAN and Cogent bezuclastinib in GIST, plus 

 neladalkib still expected in November with no day given